Hosoda Hiroshi, Kojima Masayasu, Mizushima Tsunekazu, Shimizu Shigeomi, Kangawa Kenji
Department of Biochemistry, National Cardiovascular Center Research Institute, Suita, Osaka 565-8565, Japan.
J Biol Chem. 2003 Jan 3;278(1):64-70. doi: 10.1074/jbc.M205366200. Epub 2002 Oct 31.
Ghrelin, a novel 28-amino acid peptide with an n-octanoyl modification at Ser(3), was isolated from rat stomach and found to be an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R). This octanoyl modification is essential for ghrelin-induced GH release. We report here the purification and identification of human ghrelin from the stomach, as well as structural analysis of the human ghrelin gene and quantitation of changes in plasma ghrelin concentration before and after gastrectomy. Human ghrelin was purified from the stomach by gel filtration and high performance liquid chromatography, using a ghrelin-specific radioimmunoassay and an intracellular calcium influx assay on a stable cell line expressing GHS-R to test the fractions. In the course of purification, we isolated human ghrelin of the expected size, as well as several other ghrelin-derived molecules. Classified into four groups by the type of acylation observed at Ser(3); these peptides were found to be non-acylated, octanoylated (C8:0), decanoylated (C10:0), and possibly decenoylated (C10:1). All peptides found were either 27 or 28 amino acids in length, the former lacking the C-terminal Arg(28), and are derived from the same ghrelin precursor through two alternative pathways. The major active form of human ghrelin is a 28-amino acid peptide octanoylated at Ser(3), as was found for rat ghrelin. Synthetic octanoylated and decanoylated ghrelins produce intracellular calcium increases in GHS-R-expressing cells and stimulate GH release in rats to a similar degree. Both ghrelin and the ghrelin-derived molecules were found to be present in plasma as well as stomach tissue. Plasma levels of immunoreactive ghrelin after total gastrectomy in three patients were reduced to approximately half of their pre-gastrectomy values, after which they gradually increased. This suggests that the stomach is the major source of circulating ghrelin and that other tissues compensate for the loss of ghrelin production after gastrectomy.
胃饥饿素是一种由28个氨基酸组成的新型肽,其丝氨酸(Ser)3位被正辛酰化修饰,从大鼠胃中分离出来后被发现是生长激素促分泌素受体(GHS-R)的内源性配体。这种辛酰化修饰对于胃饥饿素诱导的生长激素释放至关重要。我们在此报告从人胃中纯化和鉴定人胃饥饿素,以及对人胃饥饿素基因的结构分析和胃切除术前、后血浆胃饥饿素浓度变化的定量研究。通过凝胶过滤和高效液相色谱从人胃中纯化人胃饥饿素,使用胃饥饿素特异性放射免疫测定法以及在表达GHS-R的稳定细胞系上进行细胞内钙内流测定来检测各组分。在纯化过程中,我们分离出了预期大小的人胃饥饿素以及其他几种源自胃饥饿素的分子。根据在丝氨酸(Ser)3位观察到的酰化类型分为四组;这些肽被发现分别为未酰化、辛酰化(C8:0)、癸酰化(C10:0)以及可能的癸烯酰化(C10:1)。所有发现的肽长度均为27或28个氨基酸,前者缺少C末端的精氨酸(Arg)28,并且它们通过两条不同途径源自相同的胃饥饿素前体。人胃饥饿素的主要活性形式是一种在丝氨酸(Ser)3位被辛酰化修饰的28个氨基酸的肽,这与大鼠胃饥饿素的情况相同。合成的辛酰化和癸酰化胃饥饿素在表达GHS-R的细胞中可使细胞内钙增加,并在大鼠中以相似程度刺激生长激素释放。胃饥饿素及其衍生分子在血浆和胃组织中均有发现。三名患者全胃切除术后血浆中免疫反应性胃饥饿素水平降至术前值的约一半,之后逐渐升高。这表明胃是循环中胃饥饿素的主要来源,并且在胃切除术后其他组织可补偿胃饥饿素产生的损失。